In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, UiPath Inc’s stock clocked out at $11.22, down -1.06% from its previous closing price of $11.34. In other words, the price has decreased by -$1.06 from its previous closing price. On the day, 7.77 million shares were traded. PATH stock price reached its highest trading level at $11.41 during the session, while it also had its lowest trading level at $11.2.
Ratios:
To gain a deeper understanding of PATH’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.18. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 2.83. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Macquarie Downgraded its Outperform to Neutral on June 03, 2024, whereas the target price for the stock was revised from $29 to $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 31 ’25 when Dines Daniel sold 9,988 shares for $12.00 per share. The transaction valued at 119,856 led to the insider holds 4,598,388 shares of the business.
Dines Daniel sold 45,000 shares of PATH for $542,776 on Jul 30 ’25. The CEO and Chairman now owns 4,608,376 shares after completing the transaction at $12.06 per share. On Jul 29 ’25, another insider, Dines Daniel, who serves as the CEO and Chairman of the company, sold 45,000 shares for $12.20 each. As a result, the insider received 548,788 and left with 4,653,376 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PATH now has a Market Capitalization of 6003138048 and an Enterprise Value of 4527054848. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.14 while its Price-to-Book (P/B) ratio in mrq is 3.53. Its current Enterprise Value per Revenue stands at 3.12 whereas that against EBITDA is -51.098.
Stock Price History:
The Beta on a monthly basis for PATH is 1.03, which has changed by 0.04372096 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, PATH has reached a high of $15.93, while it has fallen to a 52-week low of $9.38. The 50-Day Moving Average of the stock is -10.71%, while the 200-Day Moving Average is calculated to be -11.48%.
Shares Statistics:
It appears that PATH traded 11.74M shares on average per day over the past three months and 14914170 shares per day over the past ten days. A total of 457.42M shares are outstanding, with a floating share count of 409.56M. Insiders hold about 23.45% of the company’s shares, while institutions hold 55.21% stake in the company. Shares short for PATH as of 1752537600 were 58879215 with a Short Ratio of 5.01, compared to 1749772800 on 54466517. Therefore, it implies a Short% of Shares Outstanding of 58879215 and a Short% of Float of 16.18.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
